Resof Total

Resof Total 400mg/100mg Tablet is used to treat chronic hepatitis C infection in adults and children 3 years and older. It works across all six main types of hepatitis C virus, is often combined with another medicine in difficult-to-treat cases.

When taken as directed by your doctor, Resof Total 400mg/100mg Tablet is highly effective, with most patients achieving a sustained virologic response. This meaning the virus is not detectable in the blood twelve weeks after completing treatment.

People should not take Resof Total 400mg/100mg Tablet if they are allergic to sofosbuvir, velpatasvir, or any ingredient in the medicine, are taking certain other medicines that strongly interact, such as rifampicin, or St. John’s wort.

Yes. Though rare, Resof Total 400mg/100mg Tablet can cause serious allergic reactions. Seek immediate medical help if you develop rash, swelling of the face or throat, trouble breathing, or severe dizziness.

Yes. If you have had hepatitis B in the past, Resof Total 400mg/100mg Tablet may cause the virus to become active again. Your doctor will test you for hepatitis B before starting Resof Total 400mg/100mg Tablet treatment, monitor you closely if needed.

Serious side effects of Resof Total 400mg/100mg Tablet include slow or irregular heartbeat, extreme tiredness, confusion, jaundice (yellowing skin or eyes), severe weakness, or unusual bleeding. Seek immediate medical attention if you experience any of these symptoms.

Yes, Resof Total 400mg/100mg Tablet is commonly used in patients with liver disease, including compensated cirrhosis (an early, often asymptomatic stage of cirrhosis where the liver is significantly scarred but still functioning well enough for the body to compensate for the damage). However, if you have decompensated cirrhosis, your doctor may prescribe Resof Total 400mg/100mg Tablet with other medicine, monitor you more closely.

Yes. When Resof Total 400mg/100mg Tablet is taken with another medicine called amiodarone, it can cause dangerous slowing of the heart rate. Patients on amiodarone need close monitoring, especially at the start of treatment.